2010
DOI: 10.1097/ccm.0b013e3181eb3ccd
|View full text |Cite
|
Sign up to set email alerts
|

Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis*

Abstract: Early combination antibiotic therapy is associated with decreased mortality in septic shock. Prospective randomized trials are needed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
230
2
14

Year Published

2012
2012
2016
2016

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 404 publications
(254 citation statements)
references
References 60 publications
8
230
2
14
Order By: Relevance
“…[4][5][6] Following such evidence-based protocols and process-of-care interventions has been shown to be associated with better patient outcomes, including decreased mortality. 7,8 Most patients with severe sepsis are cared for in intensive care units (ICUs). At times, there are no beds available in the primary ICU and patients presenting to the hospital with sepsis are cared for in other units.…”
Section: Discussionmentioning
confidence: 99%
“…[4][5][6] Following such evidence-based protocols and process-of-care interventions has been shown to be associated with better patient outcomes, including decreased mortality. 7,8 Most patients with severe sepsis are cared for in intensive care units (ICUs). At times, there are no beds available in the primary ICU and patients presenting to the hospital with sepsis are cared for in other units.…”
Section: Discussionmentioning
confidence: 99%
“…c Typically require dual broad-spectrum antibiotics with overlapping coverage [189][190][191][192]. d In patients with a history of IV drug use, those with indwelling vascular catheters or devices, or those with recent hospitalizations an agent such as daptomycin (in absence of pneumonia) or vancomycin (IF mic ≤1) or linezolid (in absence of bacteremia) should be adopted.…”
Section: Late Onset And/or Risk Factors For Mdr Organismsmentioning
confidence: 99%
“…The published meta-analysis did not stratify for the resistance status as it included mostly studies in the pre-XDR era [49][50][51]. Also, the study by Kumar et al did not focus on XDR P. aeruginosa and does not provide answers to this clinical question [52]. As few therapy options exist for XDR P. aeruginosa [53]-usually colistin, less commonly fosfomycin and aminoglycosides-combination therapy appears to be preferable based on non-clinical data of the abovementioned antibiotics.…”
Section: Use Of Combination Therapymentioning
confidence: 99%